Skip to main navigation

Corporate
Healthcare Professionals
Patients

Health Policy Resources
Contact Us

About Axonics
- Who We Are
- Leadership
Investor Relations
Careers
Contact Us

News Releases

News Releases

Year

Jul 01, 2020

Axonics® Receives FDA Approval for 3T Full-Body MRI Scans

Jun 03, 2020

Axonics® Announces U.S. Food & Drug Administration Approval of Wireless Patient Remote Control with SmartMRI Technology

May 19, 2020

Axonics® ARTISAN Results Published Demonstrating Continued Therapy Response and Patient Satisfaction at 1-year

May 12, 2020

Axonics® Announces Closing of Public Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Stock

May 07, 2020

Axonics® Announces Pricing of Public Offering of Common Stock

May 07, 2020

Axonics® Announces Proposed Public Offering of Common Stock

May 05, 2020

Axonics® Reports First Quarter 2020 Results

May 04, 2020

Axonics® to Present at Upcoming Investor Conferences

Apr 29, 2020

Axonics® Names Michael H. Carrel as Chairman of its Board of Directors

Apr 14, 2020

Axonics® Announces U.S. Food & Drug Administration Approval of Next Generation Implantable Neurostimulator

Pagination

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Page 5
Next page
Last page

Print Page Email Page Email Alerts RSS Feeds

Questions?

We are here to help answer any questions you may have about the Axonics System and Therapy.

CONTACT US

Corporate Healthcare Professionals Patients

About Axonics Investor Relations Careers Contact Us

Contact Us

©2021 Axonics Modulation Technologies, Inc. Axonics^® and Axonics Modulation Technologies^® are trademarks of Axonics Modulation Technologies, Inc., registered or pending registration in the U.S. and other countries.
Privacy Policy | Terms of Use | Important Safety Information | Sitemap